Edition:
United Kingdom

People: Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

8.61USD
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
$8.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
56,293
52-wk High
$14.35
52-wk Low
$6.20

Shurrab, Arwa 

Ms. Arwa Shurrab is Vice President - Regulatory Affairs of the Company. Ms. Shurrab brings to Catalyst nearly 25 years of regulatory affairs experience in the hematology field. She has worked extensively leading regulatory and chemistry, manufacturing and controls (CMC) activities. Before joining Catalyst, Arwa was the director of regulatory affairs at Shire, where she served as a director leading the Hematology CMC team in the development of strategic plans and worldwide regulatory submissions. Prior to Shire, she spent over 20 years at Baxter/Baxalta leading regulatory activities for hemophilia products, including but not limited to major BLA approvals and expansion to more than 70 countries. Earlier in her career, Arwa held various positions in quality control and quality assurance. Arwa holds a bachelor of science in chemistry with a minor in biology from The American University in Cairo.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --